Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High altitude cough treatment trial at Everest Base Camp
ISRCTN76835758Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Apr 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in None comparing Salmeterol + fluticasone with Placebo (2 arms). Primary endpoint: Incidence/severity of high altitude cough. Started Apr 2010; status: completed.
02
Drugs
salmeterolfluticasone
Beyond the preview
Go deeper on ISRCTN76835758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN76835758.